CN103804280A - Preparation method of donepezil HCl - Google Patents

Preparation method of donepezil HCl Download PDF

Info

Publication number
CN103804280A
CN103804280A CN201210438887.3A CN201210438887A CN103804280A CN 103804280 A CN103804280 A CN 103804280A CN 201210438887 A CN201210438887 A CN 201210438887A CN 103804280 A CN103804280 A CN 103804280A
Authority
CN
China
Prior art keywords
acid
preparation
reaction
dimethoxy
indone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210438887.3A
Other languages
Chinese (zh)
Inventor
张健
孙锦光
胡正学
王雪月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TING LIM HONG
Original Assignee
TING LIM HONG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TING LIM HONG filed Critical TING LIM HONG
Priority to CN201210438887.3A priority Critical patent/CN103804280A/en
Publication of CN103804280A publication Critical patent/CN103804280A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Abstract

The invention provides a preparation method of donepezil HCl. 5, 6-dimethoxy-2-(4-piperidyl methyl)-1-indanone (C17H23NO3) or organic acid and inorganic acid salts thereof, an organic solvent, an alkaline solution, a phase transfer catalyst are added into a reactor, and benzyl bromide is dropwise added under certain temperature; and after the reaction, the reaction products are dissolved in the solvent and acidized to obtain the donepezil HCl. The preparation method has the advanategs of high selectivity, rapid response, total yield of more than 90%, simple operation, mild condition and low cost, and is easy to realize industrialized production.

Description

A kind of preparation method of E 2020
Technical field
The present invention relates to a kind of preparation method of E 2020.
Background technology
E 2020 is the s-generation acetylcholinesterase depressant that is used for the treatment of senile dementia of FDA approval, is used for the treatment of Alzheimer's disease.It is researched and developed successfully in 1989 by Japanese Wei Cai pharmaceutical Co. Ltd, obtains FDA approval be used for the treatment of Alzheimer in November, 1996, and in January, 1997 is first in U.S.'s listing, and in October, 1999 is in Discussion on Chinese Listed, existing oneself more than 30 country's listings in the world.Its curative effect is own by Britain, the U.S., and multiple national clinical experiments such as Japan confirm.How how croak is selectively together, and reversible noncompetitive acetylcholinesterase depressant can the degraded of acetylcholine esterase inhibition to vagusstoff, activates central cholinergic system, transmits the impaired neuronal degeneration causing thereby alleviate cholinergic.It is many that how croak has selectivity highly to neuronic second phthalein Pseudocholinesterase in brain together, and the acetylcholinesterase in digestive tube and heart is not had to significant restraining effect, with respect to first-generation acetylcholinesterase depressant tacrine, there is dosage little (5-10mg), side effect is low, long-acting (70 hours transformation period, only need take once every day), the advantages such as expense is low are that treatment is light, the more valuable medicine of moderate AD.Recently, research finds how how croak is also effective to vascular dementia together, has further expanded the indication of this medicine.
The synthetic E2020 method of bibliographical information mainly contains two large classes:
Method one: EP0711756Al is by 5,6-dimethoxy-2-(4-pyridyl methylene radical)-1-indone reacts with cylite and generates after quaternary ammonium salt, then obtain E2020 by platinum oxide catalytic hydrogenation, reaction expression is as follows:
Figure 514756DEST_PATH_IMAGE001
Method two:
US2004014321Al; CN1524851A is by 5,6-dimethoxy-2-(4-pyridylmethyl)-1-indone first obtains hydride through catalytic hydrogenating reduction, then react generation E2020 with cylite, reaction expression is as follows:
5,6-dimethoxy-2-(4-piperidino methyl for CN200910228282)-1-indone, dehydrated alcohol, bromobenzyl, triethylamine back flow reaction under anhydrous condition, obtain E2020.With after through HCl-ethyl acetate salify, hydrochloride;
Figure 670985DEST_PATH_IMAGE003
CN201110391463 is by 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone is dissolved in methylene dichloride, and under triethylamine effect, react to obtain E2020 with Benzyl Chloride, then obtain E 2020 with methyl alcohol hydrogen chloride solution salify.
Contriver finds through overtesting, the technique final step Reductive stability of described method one is very poor, mainly there are the following problems: (1) thus generate more impurity because benzyl restores to be easy to take off in process, need repeatedly refine just and can remove, cause hydrogenation yield low and unstable.(2) use platinum dioxide to make catalyzer, expensive, reclaim difficulty;
And method two, the technology providing, its shortcoming be this technique final step react with cylite the product E2020 generating while connecing benzyl can further react with cylite produce a certain amount of impurity (5), cause product purity significantly to reduce, need secondary or repeatedly refine and just can remove, cause yield not high, only 70%-75%, is shown in following reaction expression:
Figure 681667DEST_PATH_IMAGE004
Therefore, provide a kind of production method of improved E2020, relevant pharmaceutical arm is extremely expected.
Summary of the invention
The object of the present invention is to provide a kind of preparation method of E 2020.
The preparation method of a kind of E 2020 of the present invention, its step comprises:
Step 1, condensation reaction, reaction formula is as follows:
Figure 587306DEST_PATH_IMAGE005
In formula, PTC is the abbreviation of phase-transfer catalyst (Phase transfer catalyst), and this reaction is phase-transfer-catalyzed reactions.
Step 2, acidifying salify, reaction formula is as follows:
In formula, substance A is 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone or 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone salt, general formula is:
Figure 332725DEST_PATH_IMAGE007
or
Figure 634131DEST_PATH_IMAGE008
HB represents organic and mineral acid.
Preparation method as above, wherein, 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone salt is 5,6-dimethoxy-2-(4-piperidino methyl)-the organic acid of 1-indone, inorganic acid salt; Wherein mineral acid is nitric acid, sulfuric acid, phosphoric acid, hydrochloric acid, Hydrogen bromide hydroiodic acid HI; Organic acid is the organic acids such as formic acid, acetic acid, propionic acid, citric acid, phenylformic acid, fumaric acid, toxilic acid.
Preparation method as above, wherein, this preparation method operates as follows: substance A, organic solvent, alkaline solution, phase-transfer catalyst are added in reactor, drip at a certain temperature cylite; After question response, reaction product is dissolved in to acidifying in certain solvent and just obtains E 2020.The mol ratio of substance A and bromobenzyl is 1:1~1:2.
Preparation method as above, wherein, solvent for use is chloroparaffin, toluene, dimethylbenzene or ethers, wherein chloroparaffin is selected from methylene dichloride, trichloromethane, 1,2 ethylene dichloride.
Preparation method as above, wherein, phase-transfer catalyst used is quaternary ammonium salt or polyoxyethylene glycol, the ratio of catalytic amount and substance A is 1:100~5:100(weight ratio).
Preparation method as above, quaternary ammonium salt is Tetrabutyl amonium bromide, hexadecyl season trimethylammonium bromide, triethyl benzyl brometo de amonio etc.; Polyoxyethylene glycol is selected from: Macrogol 200, poly(oxyethylene glycol) 400, Polyethylene Glycol-600, polyoxyethylene glycol 800, cetomacrogol 1000, Macrogol 2000.
Preparation method as above, described alkaline solution is the solution of sodium hydroxide, potassium hydroxide, or the solution of the strong base-weak acid salt such as sodium carbonate, salt of wormwood.
Preparation method as above, above-mentioned temperature of reaction is 0~40 ℃.
Preparation method as above, in above-mentioned reaction, acidifying solvent used is selected from ethyl acetate, methyl acetate, butylacetate, the ester classes such as butyl butyrate, toluene, dimethylbenzene or ethers.
Preparation method as above, acidifying salifying method used in above-mentioned reaction: the hydrogenchloride and the E2020 that utilize Acetyl Chloride 98Min. and dehydrated alcohol reaction to produce generate E 2020, and the mol ratio of Acetyl Chloride 98Min. and dehydrated alcohol is 1:1~1:30.
Beneficial effect of the present invention comprises:
1, the present invention adopts phase-transfer-catalyzed reactions, and the almost quantitative reaction of selectivity height, is swift in response, drip bromobenzyl reaction and complete, the method total recovery exceedes 90%, has easy and simple to handlely avoided anhydrous and oxygen-free reaction, condition relaxes, and temperature of reaction is upper and lower in room temperature, is easy to realize suitability for industrialized production.
2, the present invention adopts quaternary ammonium salt or polyoxyethylene glycol as catalyzer, and catalyzer is selected wide, and water is basic solution, and organic phase is chloroparaffin, toluene or ethers, and water and organic phase are practical.
3, cost of the present invention is low.
Embodiment
Below in conjunction with specific embodiment, the present invention is further illustrated.Following embodiment and being not used in should not be interpreted as by any way to the restriction of inventing in listed claim yet.Its Raw can reference example method preparation or buying on the market.
The preparation method of a kind of E 2020 provided by the invention, comprise the steps: 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone and its esters (II) with replace cylite by phase-transfer catalysis generation condensation reaction, obtain E2020; E2020 reacts the hcl reaction producing and generates E 2020 with Acetyl Chloride 98Min. and dehydrated alcohol.
Reaction expression is as follows:
Figure 710671DEST_PATH_IMAGE009
In formula, HB represents organic and mineral acid.
Wherein the mineral acid of HB representative can be nitric acid, sulfuric acid, phosphoric acid, hydrochloric acid, Hydrogen bromide hydroiodic acid HI; The organic acid of HB representative can be the organic acids such as formic acid, acetic acid, propionic acid, citric acid, phenylformic acid, fumaric acid, toxilic acid.
embodiment 1
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.5g, yield 95.2%.
embodiment 2
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, hexadecyl season trimethylammonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.1g, yield 91.8%.
embodiment 3
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), toluene 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes toluene, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.0g, yield 91.6%.
embodiment 4
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), isopropyl ether 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes isopropyl ether, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.5g, yield 92.8%.
embodiment 5
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, triethyl benzyl brometo de amonio 1.6g(5.8mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.7g, yield 93.3%.
embodiment 6
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, 1.6g Macrogol 200 mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.3g, yield 92.3%.
embodiment 7
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, 1.6g cetomacrogol 1000 mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.0g, yield 91.5%.
embodiment 8
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), trichloromethane 150ml, 20% potassium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.2g, yield 94.5%.
embodiment 9
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), trichloromethane 150ml, 20% solution of potassium carbonate 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes trichloromethane, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.5g, yield 92.8%.
embodiment 10
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to toluene and carries out acidifying salify.
2, acidifying salify
Toluene solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.0g, yield 93.9%.
embodiment 11
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to isopropyl ether and carries out acidifying salify.
2, acidifying salify
Isopropyl ether solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.9g, yield 93.7%.
embodiment 12
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to butyl butyrate and carries out acidifying salify.
2, acidifying salify
Butyl butyrate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.1g, yield 94.2%.
embodiment 13
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone 28.9g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to butyl butyrate and carries out acidifying salify.
2, acidifying salify
Butyl butyrate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.0g, yield 93.9%.
embodiment 14
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone vitriol 42.6g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to butyl butyrate and carries out acidifying salify.
2, acidifying salify
Butyl butyrate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.4g, yield 94.9%
embodiment 15
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone acetate 38.8g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to butyl butyrate and carries out acidifying salify.
2, acidifying salify
Butyl butyrate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 38.6g, yield 93.0%
embodiment 16
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone benzoate 45.0g(0.1mol), methylene dichloride 150ml, 20% sodium hydroxide solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to butyl butyrate and carries out acidifying salify.
2, acidifying salify
Butyl butyrate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.1g, yield 94.2%
embodiment 17
1, condensation reaction:
By (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone hydrochloride 32.5g(0.1mol), methylene dichloride 150ml, saturated sodium carbonate solution 300g, Tetrabutyl amonium bromide 1.6g(5.0mmol) mix, cool to 5 ℃, drip cylite 17.1g(0.1mol), dropwise rear stirring 30 minutes.Separate organic layer, anhydrous magnesium sulfate drying, filters out and concentratedly after siccative removes methylene dichloride, resistates is dissolved in to ethyl acetate and carries out acidifying salify.
2, acidifying salify
Ethyl acetate solution is cooled to 0~5 ℃, drips Acetyl Chloride 98Min. 25ml, dropwise, stir 1 hour.Drip again 35ml dehydrated alcohol, dropwise rear stirring 2 hours.Filter, obtain off-white color solid, wash solid three times by 90ml ethyl acetate, after being dried, obtain off-white color solid 39.2g, yield 94.4%.
In a word, the preparation method of a kind of E 2020 provided by the invention, technical process is simpler, cost is lower, purity is higher, is more conducive to method prepared by E 2020 that large-scale industrial produces.The method is characterised in that: 1, to prepare formula I be C24H29NO3 to the method, H Cl; 2, the raw material that the method is used is (II) 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone (C17H23NO3) or its organic acid, inorganic acid salt; 3, the present invention adopts phase-transfer-catalyzed reactions; 4, the present invention adopts quaternary ammonium salt or polyoxyethylene glycol as catalyzer, and water is basic solution, and organic phase is chloroparaffin, toluene or ethers, and 5, temperature of reaction of the present invention is 0 ℃~40 ℃; 6, selectivity is high, is swift in response, and the method total recovery exceedes 90%, easy and simple to handle, and condition relaxes, and cost is low, is easy to realize suitability for industrialized production.
The above, it is only exemplary embodiments of the present invention, not technical scope of the present invention is imposed any restrictions, any trickle modification, equivalent variations and modification that every foundation technical spirit of the present invention is made above enforcement, all still belong within the scope of technical scheme of the present invention.

Claims (10)

1. a preparation method for E 2020, its step comprises:
Step 1, condensation reaction, reaction formula is as follows:
Figure 786355DEST_PATH_IMAGE001
Step 2, acidifying salify, reaction formula is as follows:
Figure 181565DEST_PATH_IMAGE002
In formula, substance A is 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone and salt thereof, general formula is:
Figure 166576DEST_PATH_IMAGE003
or
Figure 192301DEST_PATH_IMAGE004
In formula, HB represents organic and mineral acid.
2. preparation method according to claim 1, is characterized in that 5,6-dimethoxy-2-(4-piperidino methyl)-1-indone salt is 5,6-dimethoxy-2-(4-piperidino methyl) organic acid or the inorganic acid salt of-1-indone; Wherein mineral acid is nitric acid, sulfuric acid, phosphoric acid, hydrochloric acid, Hydrogen bromide or hydroiodic acid HI; Organic acid is the organic acids such as formic acid, acetic acid, propionic acid, citric acid, phenylformic acid, fumaric acid, toxilic acid.
3. preparation method according to claim 1, is characterized in that this preparation method operates as follows: substance A, organic solvent, alkaline solution, phase-transfer catalyst are added in reactor, drip at a certain temperature cylite; After question response, reaction product is dissolved in and in solvent, carries out acidifying and just obtain E 2020;
Molar ratio 1:1~the 1:2 of substance A and bromobenzyl.
4. preparation method according to claim 3, is characterized in that solvent for use is chloroparaffin, toluene, dimethylbenzene or ethers, and wherein chloroparaffin is selected from methylene dichloride, trichloromethane, 1,2 ethylene dichloride.
5. preparation method according to claim 3, its feature is quaternary ammonium salt or polyoxyethylene glycol at phase-transfer catalyst used, the weight ratio of catalytic amount and substance A is 1:100~5:100.
6. preparation method according to claim 3, phase-transfer catalyst is quaternary ammonium salt or polyoxyethylene glycol; Quaternary ammonium salt is Tetrabutyl amonium bromide, hexadecyl season trimethylammonium bromide, triethyl benzyl brometo de amonio etc.; Polyoxyethylene glycol is selected from: Macrogol 200, poly(oxyethylene glycol) 400, Polyethylene Glycol-600, polyoxyethylene glycol 800, cetomacrogol 1000, Macrogol 2000.
7. preparation method according to claim 3, is characterized in that described alkaline solution is sodium hydroxide, potassium hydroxide, sodium carbonate, the alkaline solution of salt of wormwood or the basic solution of strong base-weak acid salt.
8. preparation method according to claim 3, is characterized in that above-mentioned temperature of reaction is 0~40 degree Celsius.
9. preparation method according to claim 3, is characterized in that in above-mentioned reaction, acidifying solvent used is selected from ethyl acetate, methyl acetate, butylacetate, the ester classes such as butyl butyrate, toluene, dimethylbenzene or ethers.
10. preparation method according to claim 1, it is characterized in that in above-mentioned reaction in acidifying salify step used: the hydrogenchloride and E2020 generation E 2020 that utilize Acetyl Chloride 98Min. and dehydrated alcohol reaction to produce, the molar ratio of Acetyl Chloride 98Min. and dehydrated alcohol is 1:1~1:30.
CN201210438887.3A 2012-11-07 2012-11-07 Preparation method of donepezil HCl Pending CN103804280A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210438887.3A CN103804280A (en) 2012-11-07 2012-11-07 Preparation method of donepezil HCl

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210438887.3A CN103804280A (en) 2012-11-07 2012-11-07 Preparation method of donepezil HCl

Publications (1)

Publication Number Publication Date
CN103804280A true CN103804280A (en) 2014-05-21

Family

ID=50701719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210438887.3A Pending CN103804280A (en) 2012-11-07 2012-11-07 Preparation method of donepezil HCl

Country Status (1)

Country Link
CN (1) CN103804280A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540520A (en) * 2019-09-12 2019-12-06 威海迪素制药有限公司 Method for purifying donepezil

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1524851A (en) * 2003-02-27 2004-09-01 天津药物研究院 Technology for industrialized production of hydrochloric acid multi-donepezil
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2007070511A1 (en) * 2005-12-12 2007-06-21 Envirodyne Technologies, Inc. Flow-through dip-spin coating method and system therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1524851A (en) * 2003-02-27 2004-09-01 天津药物研究院 Technology for industrialized production of hydrochloric acid multi-donepezil
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2007070511A1 (en) * 2005-12-12 2007-06-21 Envirodyne Technologies, Inc. Flow-through dip-spin coating method and system therefor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHAILENDRA KUMAR DUBEY,等: "A New Commercially Viable Synthetic Route for Donepezil Hydrochloride: Anti-Alzheimer’s Drug", 《CHEM. PHARM. BULL》, vol. 58, no. 9, 17 June 2010 (2010-06-17), pages 1157 - 1160 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540520A (en) * 2019-09-12 2019-12-06 威海迪素制药有限公司 Method for purifying donepezil
CN110540520B (en) * 2019-09-12 2022-02-08 迪嘉药业集团有限公司 Method for purifying donepezil

Similar Documents

Publication Publication Date Title
CN106810426B (en) Method for synthesizing cannabidiol
CN101812026B (en) Method for synthesizing bortezomib
CN112574058B (en) Synthetic route of lacosamide
CN107652180A (en) The production method of tributyrin
CN106674084B (en) A kind of preparation method of 2- isopropyl oxygroup -5- methyl -4- (piperidin-4-yl) aniline dihydrochloride
CN103044468B (en) Preparation method of N-(2-pyrazine carbonyl)-L-phenylalanine-L- leucine boracic acid
JP2011515453A (en) Method for producing donepezil hydrochloride
CN106831639B (en) The preparation method of Cefcapene side-chain acid
CN103145636B (en) 1,4-diacyl-3,6-diphenyl-1,4-dihydrotetrazine compound as well as preparation method and application thereof
CN103012268B (en) Novel preparation method for ivabradine
CN103804280A (en) Preparation method of donepezil HCl
CN107365301B (en) Synthesis method of crizotinib and preparation method of intermediate thereof
CN103242291A (en) Mass production process of polycrystalline high-content benzoic acid alogliptin
CN105272921A (en) Method for preparing Ceritinib and intermediate compound of Ceritinib
CN104326927B (en) A kind of preparation method of 1-[2-amino-1-(4-methoxyphenyl) ethyl] Hexalin sulfate
CN101195602A (en) 1-deoxidization nojiri toxin derivant, production method and uses thereof
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN110713471B (en) Synthetic method of trimetazidine hydrochloride
CN104774161B (en) Polypeptide, protein PEG dressing agent synthetic methods
CN101412678B (en) Method for synthesizing memantine hydrochloride
CN108203396B (en) Synthesis of enkephalinase inhibitor
CN105732613B (en) A kind of synthetic method of 9 demethyl (+) α dihydrotetrabenazineins
CN103804265A (en) Synthesis and post-processing method of sulpiride or optical isomer thereof
CN104761599A (en) Preparation method of 5,4'-dihydroxy flavone-7-O-D-glucuronic acid
CN101565390A (en) Method for preparing Alpha-methyl-Alpha, Alpha-disubstituted-Alpha-aminophenol and derivatives thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140521